JP2024529479A5 - - Google Patents

Info

Publication number
JP2024529479A5
JP2024529479A5 JP2024505214A JP2024505214A JP2024529479A5 JP 2024529479 A5 JP2024529479 A5 JP 2024529479A5 JP 2024505214 A JP2024505214 A JP 2024505214A JP 2024505214 A JP2024505214 A JP 2024505214A JP 2024529479 A5 JP2024529479 A5 JP 2024529479A5
Authority
JP
Japan
Prior art keywords
composition
composition according
poloxamer
active ingredient
viscosity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024505214A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024529479A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/038234 external-priority patent/WO2023009461A2/en
Publication of JP2024529479A publication Critical patent/JP2024529479A/ja
Publication of JP2024529479A5 publication Critical patent/JP2024529479A5/ja
Pending legal-status Critical Current

Links

JP2024505214A 2021-07-26 2022-07-25 膣挿入のための組成物及び技術 Pending JP2024529479A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163225872P 2021-07-26 2021-07-26
US63/225,872 2021-07-26
US202163285447P 2021-12-02 2021-12-02
US63/285,447 2021-12-02
US202263331749P 2022-04-15 2022-04-15
US63/331,749 2022-04-15
PCT/US2022/038234 WO2023009461A2 (en) 2021-07-26 2022-07-25 Compositions and techniques for vaginal insertion

Publications (2)

Publication Number Publication Date
JP2024529479A JP2024529479A (ja) 2024-08-06
JP2024529479A5 true JP2024529479A5 (https=) 2025-12-18

Family

ID=82899311

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024505214A Pending JP2024529479A (ja) 2021-07-26 2022-07-25 膣挿入のための組成物及び技術

Country Status (5)

Country Link
US (1) US20240189265A1 (https=)
EP (1) EP4376890A2 (https=)
JP (1) JP2024529479A (https=)
AU (1) AU2022319690A1 (https=)
WO (1) WO2023009461A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024155777A2 (en) * 2023-01-19 2024-07-25 Dare Bioscience, Inc. Compositions and techniques for treatment of polycystic ovarian syndrome (pcos) and endometriosis
WO2024155775A2 (en) * 2023-01-19 2024-07-25 Dare Bioscience, Inc. Compositions and techniques for treatment of polycystic ovarian syndrome (pcos) and endometriosis
WO2024158951A2 (en) * 2023-01-25 2024-08-02 Dare Bioscience, Inc. Compositions and methods for treating dysmenorrhea
WO2025212773A1 (en) * 2024-04-03 2025-10-09 Daré Bioscience, Inc. Lactobacillus gel formulation and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6825234B2 (en) * 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
US20030206958A1 (en) * 2000-12-22 2003-11-06 Cattaneo Maurizio V. Chitosan biopolymer for the topical delivery of active agents
US20060189552A1 (en) * 2000-12-12 2006-08-24 Mohan Vishnupad Dispenser for dispensing three or more actives
EP2010133B1 (en) * 2006-03-31 2016-05-04 Stiefel Research Australia Pty Ltd Foamable suspension gel
EA030035B1 (ru) * 2007-11-06 2018-06-29 Меламед, Лемуил Применение s-этилизотиоурония диэтилфосфата для изготовления лекарственного средства для лечения нарушения матки
EP2242476A2 (en) * 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
EP2520279A1 (en) * 2011-05-02 2012-11-07 TERES S.r.l. Thermoreversible gel pharamaceutical compositions for odontoiatric use
WO2014042604A1 (en) * 2012-09-11 2014-03-20 Imuneks Farma Mac Sanayi Ve Ticaret A.S. Clindamycin phosphate, salicylic acid and tea tree oil combinations
AU2013362794B2 (en) * 2012-12-20 2018-02-22 Smilesonica Inc. Internal ultrasound gel
WO2017015232A1 (en) * 2015-07-20 2017-01-26 Trilogic Pharma Llc Topical formulations and treatments
BR112021008100A2 (pt) * 2018-11-05 2021-08-03 Inspired Material Solutions, LLC carreador e protetor de pele dérmico

Similar Documents

Publication Publication Date Title
JP2024529479A5 (https=)
US5912007A (en) Delivery system for the localized administration of medicaments to the upper respiratory tract and methods for preparing and using same
JPH09510468A (ja) 皮膚疾患の治療のための及びその皮膚の消毒のためのゲル
JP2001527574A (ja) 眼科用組成物
JPH0338250B2 (https=)
TW201143783A (en) Non-irritating ophthalmic povidone-iodine compositions
JPH0315606B2 (https=)
JP2001508038A (ja) 粘膜表面および身体組織に付与可能な薬学的ゲル調製物
CN1422142A (zh) 药用组合物
TW200916125A (en) Concentrated aqueous azalide formulations
JP2002536387A (ja) 持続的放出生体接着膣投与剤
JPH06506472A (ja) イブプロフェン−鎮咳薬配合物
JPH10508833A (ja) 痔核用組成物および使用方法
JP2002537070A (ja) 生体接着性抗菌性創傷治癒用組成物
MX2011001739A (es) Composiciones mucoadherentes y sus usos.
JP2022070924A (ja) アルギン酸をベースとする抗菌性化合物を使用して炎症と疾患を阻害するための組成物及び方法
JP2005518435A5 (https=)
JP7359909B2 (ja) 口腔用組成物の製造方法、口腔用組成物の口腔内塗布部との密着性を向上させる方法および口腔用組成物の口腔内塗布部における滞留性を向上させる方法。
CN104470498A (zh) 含有低聚乳酸的药物组合物
BR112014030984B1 (pt) Composições e métodos para aumentar a eficácia de microbicidas contraceptivos
CN115444812B (zh) 一种具有单面生物粘附性的黏膜粘附材料及其制备方法
CA2840727A1 (en) Compositions and methods for the treatment of ocular surface allergies
TWI909127B (zh) 含有麩醯胺酸的藥物組成物、製劑及其用途
JPH101441A (ja) 局所麻酔組成物
JP7655568B2 (ja) 粘膜又は皮膚における炎症状態の治療